CN Patent

CN103804323A — 一种卡巴他赛溶剂化物及其制备方法和应用

Assigned to Aopudun (shanghai) Medical Technology Co Ltd · Expires 2014-05-21 · 12y expired

What this patent protects

本发明公开了一种卡巴他赛溶剂化物及其制备方法和应用。所述溶剂化物是由卡巴他赛与乙酸乙酯发生溶剂化后形成的结晶体，含有质量比为8～10%的乙酸乙酯。本发明提供的卡巴他赛溶剂化物具有稳定性好且吸湿性弱等优点，有利于制备质量符合标准的制剂；且其制备方法具有操作简单、质量稳定、得率高、成本低、节能环保等显著优点，符合工业化生产要求，具有极强的实用价值和广阔的应用前景。

USPTO Abstract

本发明公开了一种卡巴他赛溶剂化物及其制备方法和应用。所述溶剂化物是由卡巴他赛与乙酸乙酯发生溶剂化后形成的结晶体，含有质量比为8～10%的乙酸乙酯。本发明提供的卡巴他赛溶剂化物具有稳定性好且吸湿性弱等优点，有利于制备质量符合标准的制剂；且其制备方法具有操作简单、质量稳定、得率高、成本低、节能环保等显著优点，符合工业化生产要求，具有极强的实用价值和广阔的应用前景。

Drugs covered by this patent

Patent Metadata

Patent number
CN103804323A
Jurisdiction
CN
Classification
—
Expires
2014-05-21
Drug substance claim
No
Drug product claim
No
Assignee
Aopudun (shanghai) Medical Technology Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.